HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.
about
HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatmentPulmonary hypertension: diagnostic and therapeutic challengesHuman immunodeficiency virus-associated pulmonary arterial hypertensionFactors associated with isolated right heart failure in women: a pilot study from western KenyaWhy the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transitionMechanisms Underlying HIV Associated Non-infectious Lung Disease.Microvascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIV.Pulmonary arterial hypertension related to human immunodeficiency virus infection: A case series.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertensionPulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspectiveSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Challenges in managing pulmonary hypertension in the developing countries.Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.Infections in the immunosuppressed hostNoninfectious pulmonary complications of human immunodeficiency virus infectionAn official American Thoracic Society Statement: pulmonary hypertension phenotypesPathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef.Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction.Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats.The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesHypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling.Human immunodeficiency virus transgenic rats exhibit pulmonary hypertensionPulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the LiteratureEndothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection.Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States.Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine.HIV-1, reactive oxygen species, and vascular complicationsPathogenesis of HIV and the lungCardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.Waiting to inhale: An exploratory review of conditions that may predispose to pulmonary hypertension and right heart failure in persons exposed to household air pollution in low- and middle-income countries.Human immunodeficiency virus and pulmonary arterial hypertension.Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension.HIV infection and pulmonary arterial hypertension.Experimental and transgenic models of pulmonary hypertension.Cardiovascular involvements in HIV-infected patients.HIV and the heart: the impact of antiretroviral therapy: a global perspective.HIV-associated pulmonary arterial hypertension: from bedside to the future.Maintaining lung health with longstanding HIV.Pharmacological treatment of HIV-associated pulmonary hypertension.Non-infectious Pulmonary Diseases and HIV.Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
P2860
Q26777241-2D5C7F0F-7F9C-4654-ADC9-3C4A61B8E30BQ26796434-CCF5386D-8EB0-47DE-8EAE-047229E3FB23Q26824782-C33DAEF9-DBCC-46A4-B850-F05779C639FEQ28392263-134C145F-4DD4-4865-91DF-3BE0F811CB69Q28393479-8C718AA3-A951-4BD4-B19C-306D5175EAD9Q30234727-A5C6E3CF-BFEC-4D35-9657-71DB1AB7D4C0Q33792101-18CC487C-E886-46A3-9EA0-AA722B41FB66Q33812960-A36DE907-54E2-487C-A1D0-54F168BBA9F5Q33898213-672BCFC8-A5C5-4CBC-85ED-2EEFCE50B309Q33899409-1E9602A6-527A-4814-9F6A-9899A93DD29BQ33965891-72E0282E-ED33-4CAE-8F6A-51D89DC42D90Q34109306-B7C72149-FE33-49FA-8304-BDF4C9990640Q34357428-1AF5122F-8F45-4C91-AC54-0FA35239745AQ34564288-5339F9A7-D7EC-48FD-81F4-8B556059B370Q34919733-0ACAB443-CEAA-4B1C-A738-DD5628B9FD28Q35095050-61832AFA-47D8-4C33-8032-9E735BD4F04CQ35132178-05094589-3B14-46B0-A480-20464222F42BQ35151656-BF833A0F-F336-4BAE-A5B6-207709672F2CQ35156618-81905E31-2A38-40F2-AAF5-54C4A9061B09Q35184983-991F3103-CA7B-435B-A08D-94E6C47CE74CQ35217383-52FB7346-30B8-42CA-BDAC-0DC0D06E8DACQ35296597-A6F6F471-F9D1-40BB-B763-C3C56E0D46B3Q35890439-82075B77-9970-4766-8E81-D66952F69707Q36016513-06453A2F-E977-45BC-8C57-5D2D14C96284Q36026281-613B27C6-1974-4A7D-AA9B-CDBDAC04D5DFQ36040759-06D68F3D-9612-4AEA-AE4F-D9AE10456072Q36594970-7B28EF48-C620-4399-B9ED-ECCF6A36F6CEQ36709815-22110374-8479-405C-BDC3-71FE1E5FC43BQ36841937-24757A69-4F1B-4C9F-BB75-BBF2D1BA8C16Q37148558-C10D4223-82AC-412F-8FFB-7CBFC1EA190BQ37481861-022154E8-084F-43E2-807F-317D3FB57837Q37867676-4AC42E3B-32A0-4588-92D4-1C1DC696522FQ38112056-FD945D1E-ABC2-48DB-B75E-B3BFBEA0C4C4Q38131061-9D1F2042-96D7-4F37-9852-D3FD2C0A8C5FQ38152708-82C1F5E0-6D75-4008-9500-02EBC4C5346AQ38365222-F72EDD19-CB90-412D-9654-7D26DAB8E8C2Q38629654-A9A98F0A-63BD-4347-A461-66DFA6A11098Q38728500-9E90D7E5-062D-4AB8-A043-5FDD05FE08A6Q38819315-55611E42-E06C-4A64-B813-11A2AC64C58DQ39082532-BEC28F8C-48AA-4CD4-A329-BB5254A1DC87
P2860
HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-associated pulmonary arter ...... in the modern therapeutic era.
@en
HIV-associated pulmonary arter ...... in the modern therapeutic era.
@nl
type
label
HIV-associated pulmonary arter ...... in the modern therapeutic era.
@en
HIV-associated pulmonary arter ...... in the modern therapeutic era.
@nl
prefLabel
HIV-associated pulmonary arter ...... in the modern therapeutic era.
@en
HIV-associated pulmonary arter ...... in the modern therapeutic era.
@nl
P2093
P50
P1433
P1476
HIV-associated pulmonary arter ...... in the modern therapeutic era
@en
P2093
Azzedine Yaici
Bruno Degano
Gérald Simonneau
Laurent Savale
Mathilde Guillaume
P356
10.1097/QAD.0B013E328331C65E
P407
P577
2010-01-01T00:00:00Z